Skip to content

What We Offer

Advisory Services

Beyond capital, we provide strategic guidance and hands-on support to help our portfolio companies navigate the complex journey from innovation to market.

What We Do

Our Advisory Services

Comprehensive capital, advisory, and innovation solutions for life sciences and biopharma

BD&L Advisory

End-to-end business development and licensing support — from target identification and diligence through valuation, negotiation, and deal execution.

M&A Transactions

Strategic advisory on mergers, acquisitions, and divestitures, including buy-side and sell-side mandates across the biopharma and life sciences landscape.

Capital Raise

Structuring and execution of equity and debt financings, including venture capital, private equity, venture debt, and other non-dilutive financing solutions.

Commercial Strategy

Holistic commercial guidance across Value & Access, go-to-market, growth marketing, Medical Affairs, and payer and provider functions.

Primary Market Research

Proprietary research and data-driven insights to validate hypotheses, size markets, and inform strategic decisions across therapeutic areas.

Corporate Advisory

Shareholder value maximization, portfolio optimization, restructuring, and performance improvement to strengthen organizational positioning.

Why 11Scientific

What Sets Us Apart

Four pillars that define how we deliver value to every client engagement

Integrated Model

We combine investment banking rigor with deep scientific expertise — providing clients with a 360° view across deal structuring, clinical strategy, and commercial execution.

Sector Focus

Exclusively focused on life sciences, biopharma, medical devices, and health-tech — giving us unmatched depth across therapeutic areas, modalities, and ecosystem stakeholders.

Data-Driven Insights

Proprietary accelerators, primary research capabilities, and analytical frameworks that surface actionable intelligence from complex scientific and commercial data sets.

Execution Agility

Lean, senior-led teams that move quickly from strategy to execution — reducing friction at every stage of the transaction or advisory process.

Core Capabilities

Our Expertise

Comprehensive solutions across capital, advisory, and innovation

1

Capital

  • Mergers & Acquisitions
  • Licensing
  • Capital Raise
  • IPO Planning
  • Private Capital
  • Venture Debt
  • Other Non-Dilutive Financing
2

Advisory

  • BD&L Advisory
  • Corporate Advisory
  • Shareholder Value Maximization
  • Portfolio Advisory
  • Product Advisory
3

Innovation

  • Asset / Platform Technology Build-out
  • New Product Development
  • Restructuring and Performance Improvement
  • Ecosystem Development

Our Process

BD&L Advisory Process

A structured, six-stage approach to business development and licensing engagements

01

Strategy & Scoping

Define objectives, asset profile, and target partnership criteria

02

Target Identification

Map the landscape using proprietary databases and primary research

03

Outreach & Engagement

Senior-led outreach to qualified counterparties and key decision-makers

04

Diligence & Valuation

Scientific, commercial, and financial diligence with rigorous NPV modelling

05

Negotiation & Structuring

Term sheet development, deal structuring, and negotiation support

06

Close & Post-Deal

Transaction execution, regulatory filings, and post-close integration support

Work With Us

Partner With Us

If you're building a transformative life science company, we'd love to hear from you.

Get in Touch